1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
DISTIGMlNE BROMIDE (UBRETID) FOR THE PREVENTION OF URINARY RETENTION AFTER VAGINAL HYSTERECTOMY
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1972.tb15812.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 79, Issue 4, pages 377–378, April 1972
Additional Information
How to Cite
Walsh, J. and Bonnar, J. (1972), DISTIGMlNE BROMIDE (UBRETID) FOR THE PREVENTION OF URINARY RETENTION AFTER VAGINAL HYSTERECTOMY. BJOG: An International Journal of Obstetrics & Gynaecology, 79: 377–378. doi: 10.1111/j.1471-0528.1972.tb15812.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Abstract
- References
- Cited By
Summary
After vaginal hysterectomy patients were given intramuscular injectinons of Ubretid or of a placebo. No significant difference was found in the number of patients requiring catheterization or in the incidence of postoperative urinary tract infection in the treated and control groups.